+ H]+. Anal. Calcd for for C57H60Cl3N3O9: C, 65.99; H, 5.83; N,
4.05. Found: C, 65.82; H, 5.92; N, 3.93.
of compounds 1 with anionic guests. Upon the addition of
anions, the absorption spectra of 1 changed (see Table S1,
Supporting Information). From the derived stability constants
(Table 1) of compound 1 complexes with anions, it can be
concluded that 1 prefers to complex F- over the other anions
tested by forming 1:1 complexes.
Synthesis of N-Benzylhexahomotriaza-p-chlorocalix[3]trinap-
thylamide (1). A solution of 2a (0.135 g, 0.130 mmol) was charged
with a solution of 1-napthymethylamine (0.072 g, 0.456 mmol) in
1:1 methanol:toluene mixture (10 mL). The solution was refluxed
for 3 days. After removing the solvents, the crude mixture was
purified by column chromatography of the precipitate on silica gel
(hexane/EtOAc ) 3:2, v/v), which gave 1 (0.073 g, 0.053 mmol,
41%) as a white solid. A solution of 2b (0.207 g, 0.200 mmol)
was charged with a solution of 1-napthymethylamine (0.207 g, 0.700
mmol) in 1:1 methanol:toluene mixture (10 mL). The solution was
refluxed for 7 days. After removing the solvents, the crude mixture
was purified by column chromatography of the precipitate on silica
gel (hexane/EtOAc ) 3:2, v/v), which gave 1 (0.114 g, 0.087 mmol,
In summary, the partial-cone conformation of N-benzyl-
hexahomotriaza-p-chlorocalix[3]trinaphthylamide (1) was se-
lectively synthesized from both cone and partial-cone triester
intermediates coupling with 1-aminomethylnaphthalene. The
crystal structures of 1 and 2a were confirmed by X-ray
1
crystallography. On the basis of fluorescent, UV-vis, and H
NMR spectra changes upon cation and anion complex formation,
it has been noted that 1 displays strong binding with Cd2+ (by
using nitrogen at the azacalix[3]arene framework), Pb2+ and
Co2+ (by using the carbonyl of amide groups from the side of
azacaliz[3]arene containing two naphthyl groups), and F- (by
using hydrogen bonds between the NH part of the amide with
anions).
1
42%) as a white solid: H NMR (400 MHz, CDCl3) δ 8.10-8.08
(m, 3H, ArHnap), 8.01-7.97 (m, 4H, ArHnap), 7.91 (d, JH-H ) 7.2
Hz, 2H, ArHnap), 7.64-7.57 (m, 8H, ArHnap), 7.64-7.57 (m, 4H,
ArHnap), 7.32-7.21 (m, 9H, ArHcalix), 7.14 (d, JH-H ) 6.8 Hz, 2H,
ArHcalix), 7.09 (d, JH-H ) 7.6 Hz, 4H, ArHcalix), 7.02 (s, 1H,
CH2NHCO), 6.86 (s, 2H, CH2NHCO), 6.51 (s, 2H, ArHcalix), 6.44
(s, 2H, ArHcalix), 6.36 (s, 2H, ArHcalix), 5.11 (d, JH-H ) 4.8 Hz,
2H, ArCH2NH), 5.04 (d, JH-H ) 5.6 Hz, 1H, ArCH2NH), 5.00 (d,
JH-H ) 4.8 Hz, 1H, ArCH2NH), 4.93 (d, JH-H ) 4.8 Hz, 1H,
ArCH2NH), 4.89 (d, JH-H ) 5.2 Hz, 1H, ArCH2NH), 3.91 (d, JH-H
Experimental Section
Synthesis of N-Benzylhexahomotriaza-p-chlorocalix[3]tri(ethyl
acetate) (2). The synthetic procedures of 2a and 2b have been
modified from our previous work11 by replacing the methyl
bromoacetate with ethyl bromoacetate. Column chromatography on
silica gel (hexane/EtOAc ) 9:1, v/v) of crude product afforded a
21% yield of 2a (X-ray data demonstrated in the Supporting
) 15.2 Hz, 2H, ArCH2N), 3.80 (s, 2H, OCH2CO), 3.58 (d, JH-H
)
14.8 Hz, 2H, ArCH2N), 3.09 (s, 2H, OCH2CO), 2.99-2.71 (m,
12H, ArCH2N and OCH2CO), 2.57 (d, JH-H ) 12.8 Hz, 2H,
ArCH2N), 2.28 (d, JH-H ) 14.0 Hz, 2H, ArCH2N); 13C NMR (100
MHZ, CDCl3) δ 167.3, 167.2, 153.1, 152.0, 138.6, 137.8, 134.2,
134.1, 133.5, 133.3, 133.1, 132.5, 131.7, 131.5, 130.2, 130.1, 129.7,
129.5, 129.3, 129.2, 129.1, 129.0, 128.8, 128.7, 128.5, 128.4, 128.3,
127.7, 127.5, 127.1, 127.0, 126.4, 126.3, 126.0, 125.5, 123.9, 123.6,
72.8, 71.4, 63.0, 60.0, 52.7, 52.5, 52.0, 41.6, 41.2; IR (KBr) ν 3419,
3059, 2921, 2837, 2810, 1679, 1594, 1524, 1436, 1364, 1251, 1193,
1124, 1041, 884, 797, 789, 745, 701 cm-1; MS (MALDI-TOF)
calcd for [C84H75Cl.3N6O6]+ m/z 1368.48, found 1369.67 [M + H]+.
Anal. Calcd for C84H75Cl.3N6O6: C, 73.59; H, 5.51; N, 6.31. Found:
C, 73.56; H, 5.53; N, 6.14.
1
Information) (0.135 g, 0.130 mmol) as a deep yellow oil. 2a: H
NMR (400 MHz, CDCl3) δ 7.34-7.26 (m, 12H, ArH), 7.18 (t,
3H, JH-H ) 7.2 Hz, ArH), 6.90 (s, 6H, ArH), 4.28 (s, 6H,
OCH2CO), 4.22 (q, 6H, JH-H ) 7.6 Hz, OCH2CH3), 3.61 (s, 6H,
NCH2Ar), 3.44 (dd, 12H, JH-H ) 14.4, 7.6 Hz, NCH2Ar), 1.28 (t,
9H, JH-H ) 7.2 Hz, OCH2CH3); 13C NMR (100 MHZ, CDCl3) δ
169.1, 152.3, 139.2, 133.9, 130.1, 129.0, 128.9, 128.9, 128.6, 127.3,
71.0, 62.4, 52.5, 52.1, 14.4; IR (KBr) ν 3063, 3028, 2981, 2929,
2803, 1757, 1448, 1372, 1292, 1188, 1118, 1065, 1030, 879, 743,
701 cm-1; MS (MALDI-TOF) calcd for [C57H60Cl3N3O9]+ m/z
1035.34, found 1036.92 [M + H]+. Anal. Calcd for C57H60Cl3N3O9:
C, 65.99; H, 5.83; N, 4.05. Found: C, 65.95; H, 5.71; N, 4.00. 2b
Acknowledgment. The authors gratefully acknowledge the
ThailandResearchFund(TRF)forfinancialsupport(RMU4880041
and RTA4880008) and the Royal Golden Jubilee Ph.D. Program
of TRF (PHD/0137/2546).
1
(pale yellow solid, 31%): H NMR (400 MHz, CDCl3) δ 7.57 (d,
J ) 7.6 Hz, 2H, ArH), 7.31 (t, J ) 7.6 Hz, 3H, ArH), 7.38-7.30
(m, 10H, ArH), 7.02 (s, 4H, ArH), 6.98 (s, 2H, ArH), 4.31 (br d,
2H, OCH2CO), 4.15 (s, 4H, OCH2CH3), 4.13 (s, 2H, OCH2CH3),
4.11 (br d, 2H, OCH2CO), 3.79-3.22 (m, 20H, OCH2CO and
NCH2Ar), 1.24 (m, 9H, OCH2CH3); 13C NMR (100 MHz, CDCl3)
δ 169.1, 169.0, 155.8, 154.1, 139.4, 138.6, 134.8, 133.4, 132.9,
131.6, 130.4, 129.6, 129.3, 129.2, 128.8, 128.5, 128.4, 128.1, 127.4,
127.3, 70.8, 70.3, 63.0, 60.9, 59.4, 53.0, 52.7, 52.4, 14.4, 14.3; IR
(KBr) ν 3063, 3028, 2981, 2922, 2852, 2804, 1756, 1446, 1376,
1291, 1187, 1121, 1063, 1030, 891, 743, 700 cm-1; MS (MALDI-
TOF) calcd for [C54H54Cl3N3O9]+ m/z 1035.34, found 1036.92 [M
Supporting Information Available: Experimental proce-
dures and spectroscopic data for all new compounds including
NMR spectra and crystal structures of N-benzylhexahomotri-
aza-p-chlorocalix[3]trinaphthylamide (1) (CIF) and N-benzyl-
hexahomotriaza-p-chlorocalix[3]tri(ethyl acetate) (2a) (CIF).
This material is available free of charge via the Internet at
JO800461R
J. Org. Chem. Vol. 73, No. 14, 2008 5577